Insmed's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Insmed is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is €-1.14. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 79.07M	$ 77.23M	$ 65.21M	$ 59.30M	$ 67.73M
Gross Profit	$ 62.37M	$ 60.63M	$ 51.38M	$ 46.23M	$ 54.26M
EBIT	$ -138.10M	$ -223.66M	$ -139.28M	$ -143.55M	$ -127.42M
EBITDA	$ -132.83M	$ -218.40M	$ -134.37M	$ -142.29M	$ -125.31M
Net Income Common Stockholders	$ -158.93M	$ -244.81M	$ -159.78M	$ -160.08M	$ -131.15M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 785.94M	$ 917.79M	$ 998.67M	$ 1.15B	$ 513.29M
Total Assets	$ 1.32B	$ 1.44B	$ 1.52B	$ 1.66B	$ 994.82M
Total Debt	$ 1.20B	$ 1.19B	$ 1.18B	$ 1.18B	$ 829.77M
Net Debt	$ 411.26M	$ 269.86M	$ 186.04M	$ 29.62M	$ 316.48M
Total Liabilities	$ 1.61B	$ 1.59B	$ 1.56B	$ 1.66B	$ 1.02B
Stockholders Equity	$ -289.36M	$ -155.75M	$ -44.65M	$ 87.95M	$ -29.96M
Cash Flow	-
Free Cash Flow	$ -139.19M	$ -137.22M	$ -140.16M	$ -106.04M	$ -90.41M
Operating Cash Flow	$ -136.33M	$ -132.34M	$ -136.76M	$ -101.35M	$ -89.83M
Investing Cash Flow	$ 7.15M	$ -264.66M	$ 32.10M	$ 18.52M	$ 49.42M
Financing Cash Flow	$ 1.25M	$ 44.33M	$ -399.00K	$ 743.39M	$ 37.12M

Currency in USD

Insmed Earnings and Revenue History

Income Statement >

Insmed Debt to Assets

Balance Sheet >

Insmed Cash Flow

Cash Flow >

Insmed Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing